Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays

ClinicalTrials.gov ID: NCT02382211

Public ClinicalTrials.gov record NCT02382211. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Trial to Evaluate the Correlation of T-SPOT® Response to CMV Infection and T Cell-mediated Acute Graft Rejection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The T-SPOT assay quantifies the number of peripheral blood interferon-γ producing effector T cells \[spot forming cells/million peripheral blood mononuclear cells - PBMC)\]. The T-SPOT platform technology can be applied to diagnose and monitor any major disease process driven by a T cell response, including a viral disease such as cytomegalovirus (CMV) infection (the T-SPOT.CMV assay) or an allograft rejection (the T-SPOT.PRT assay).

Study identification

NCT ID
NCT02382211
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Oxford Immunotec
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2015 (Type not available)
Primary completion
Sep 2017 (Actual)
Completion
Sep 2017 (Actual)
Last update posted
Apr 25, 2019

2015 – 2017

United States locations

U.S. sites
35
U.S. states
19
U.S. cities
33
Facility City State ZIP Site status
University of Arizona Tucson Arizona 85721 —
University of California Irvine California 92868 —
Loma Linda University Medical Center Loma Linda California 92354 —
Transplant Research Institute Los Angeles California 90057 —
University of California - San Francisco San Francisco California 94143 —
California Pacific Medical Center San Francisco California 94415 —
University of Colorado Aurora Colorado 80045 —
Georgetown University Washington D.C. District of Columbia 20007 —
Tampa General Hospital Tampa Florida 33606 —
Cleveland Clinic Weston Florida 33331 —
Emory University Atlanta Georgia 30322 —
Georgia Regents University Augusta Georgia 30912 —
Ochsner Clinic Foundation New Orleans Louisiana 70130 —
U Maryland Baltimore Maryland — —
Massachusetts General Hospital Boston Massachusetts 02144 —
Washington University St Louis Missouri 63110 —
U Nebraska Omaha Nebraska — —
St Barnabas Medical Center Livingston New Jersey — —
Albany Medical Center Albany New York — —
Erie County Medical Center Buffalo New York 14215 —
ICON School of Medicine at Mt Sinai New York New York 10029 —
SUNY Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10467 —
University of Cincinnati Cincinnati Ohio 45219 —
Case Medical Center Cleveland Ohio 44106 —
University of Toledo Medical Center Toledo Ohio — —
Legacy Transplant Services Portland Oregon 92710 —
Medical University of South Carolina Charleston South Carolina 29425 —
Baylor University Medical Center Dallas Texas 75246 —
Baylor All Saints Medical Center Fort Worth Texas 76104 —
Houston Methodist Houston Texas 77030 —
Baylor College of Medicine Houston Texas — —
Intermoutain Health Care Salt Lake City Utah 84107 —
University of Washington Seattle Washington 98122 —
Providence Health and Services Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02382211, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 25, 2019 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02382211 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →